Daprodustat

「Daprodustat」熱門搜尋資訊

「Daprodustat」文章包含有：「Jesduvroq（daprodustat）核可適用於慢性腎病引起之貧血...」、「慢性腎病貧血藥進展，GSK更新美國FDA新藥審查進度」、「《FDA》核准葛蘭素(GSK)慢性腎臟病引起貧血口服新藥...」、「Daprodustat」、「DaprodustatfortheTreatmentofAnemiainPatientsNot...」、「EffectsofDaprodustat」、「Daprodustat」、「Daprodustat」、「Jesduvroq(daprodustat)approvedbyUSFDAforanaemia...」、「EfficacyandSafetyofDaprodustatforTr...

Provide From Google

Jesduvroq （daprodustat）核可適用於慢性腎病引起之貧血 ...

https://www.taiwan-pharma.org.

Jesduvroq（daprodustat）每日口服一次，飯前、飯後皆可，給藥起始劑量需依照患者紅血球程度、肝功能與其他治療等因素作調整，有五種劑量之錠劑：1 mg、2 mg、4 mg、6 mg ...

Provide From Google

慢性腎病貧血藥進展，GSK 更新美國FDA 新藥審查進度

https://geneonline.news

Daprodustat 是一種新型口服缺氧誘導因子脯氨酰羥化酶抑製劑(hypoxia-inducible factor prolyl hydroxylase inhibitor, HIF-PHI) ，用於治療罹患CKD 非 ...

Provide From Google

《FDA》核准葛蘭素(GSK)慢性腎臟病引起貧血口服新藥 ...

http://www.genetinfo.com

在日本，daprodustat 的品牌名稱是Duvroq，是市場領導者和首選HIF-PHI。 ASCEND III 期臨床試驗. 包括五項III 期試驗，以評估daprodustat 治療CKD 貧血的 ...

Provide From Google

Daprodustat

https://en.wikipedia.org

Daprodustat, sold under the brand name Duvroq among others, is a medication that is used for the treatment of anemia due to chronic kidney disease.

Provide From Google

Daprodustat for the Treatment of Anemia in Patients Not ...

https://www.nejm.org

Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. In patients with chronic kidney disease (CKD) who are not ...

Provide From Google

Effects of Daprodustat

https://pubmed.ncbi.nlm.nih.go

Background: Daprodustat (GSK1278863) is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor being developed for treatment of anemia associated with ...

Provide From Google

Daprodustat

https://pubmed.ncbi.nlm.nih.go

Daprodustat (DUVROQ) is a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase (PHD) developed by GlaxoSmithKline for the treatment of ...

Provide From Google